54 results on '"Behera, Madhusmita"'
Search Results
2. Molecular testing and patterns of treatment in patients with NSCLC: An IASLC analysis of ASCO CancerLinQ Discovery Data.
3. Association of concomitant NSAID and immunotherapy on outcomes in patients with non-small cell lung cancer: Analysis of the National Veterans Health Administration Database.
4. Effect of antibiotic therapy on immunotherapy outcomes for non-small cell lung cancer: Analysis from the Veterans Health Administration Database.
5. Association of azole antifungals with survival in patients with non-small cell lung cancer receiving immunotherapy.
6. Association of proton pump inhibitors with survival in Veterans with non-small cell lung cancer receiving immunotherapy.
7. Clinical features and outcomes of colloid carcinoma of pancreas compared to pancreatic ductal adenocarcinoma.
8. Utilization patterns of immune checkpoint inhibitors (ICI) for non-small cell lung cancer (NSCLC) within the veterans health administration (VHA).
9. KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.
10. Efficacy of daratumumab + SOC versus SOC in myeloma induction regimens, by risk-stratification: Meta-analysis of phase III randomized control trials.
11. Impact of tumor side on clinical outcomes in stage II and III colon cancer with known microsatellite instability status.
12. Is adjuvant chemotherapy beneficial for stage II-III goblet cell tumors of the appendix?
13. Impact of high-risk features for stage II adenocarcinoma of the appendix.
14. Perioperative therapy in patients with metastatic colorectal cancer.
15. The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma.
16. Role of resection of the primary in metastatic well/intermediate-differentiated neuroendocrine tumor (NET).
17. Evaluating the role of race in outcome of advanced non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitor (ICI): Our institutional experience.
18. Clinical outcomes of hepatocellular carcinoma variants compared to hepatocellular carcinoma.
19. Survival outcomes in gastric and gastroesophageal junction adenocarcinoma treated with peri-operative chemotherapy with or without pre-operative radiotherapy.
20. Incidence, treatment and survival outcomes of small bowel adenocarcinomas: A National Cancer Database (NCDB) analysis.
21. Impact of adjuvant chemotherapy in higher risk stage II colon cancer with a deficient mismatch repair (dMMR)/ microsatellite instability-high (MSI-H) profile.
22. Racial and socioeconomic disparities in mantle cell lymphoma.
23. Outcomes in non-Hodgkin lymphoma by Latino country-of-origin (COO).
24. Epidemiology and treatment of high-grade gastrointestinal neuroendocrine tumors (HG-GI-NETs).
25. Survival outcomes in extensive stage small cell lung cancer patients treated with thoracic radiation.
26. Characteristics and outcomes of patients (pts) with metastatic KRAS mutant lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC) database.
27. Treatment, outcomes, and impact of racial disparities on young adults with pancreatic cancer.
28. Racial disparities in treatment and outcomes of colorectal cancer in young adults.
29. Early proliferation of PD-1+ CD8 T cells in peripheral blood as predictive of response to PD-1 inhibition for patients with advanced NSCLC.
30. Chemotherapy with or without definitive radiation therapy in locally advanced pancreatic cancer.
31. Optimal thoracic radiation dose in limited stage small cell lung cancer.
32. Evaluation of toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer (NSCLC).
33. National Cancer Data Base analysis of proton versus photon radiotherapy in non-small cell lung cancer (NSCLC).
34. Non-small cell lung cancer (NSCLC) as a second primary: Analysis of the National Cancer Data Base (NCDB).
35. Role of anti-EGFR monoclonal antibody in EGFR FISH positive NSCLC patients: A meta-analysis of phase III randomized controlled trials.
36. Liver metastases and sensitivity to checkpoint inhibition in patients with non-small cell lung cancer (NSCLC).
37. Investigating the correlation between disease burden and symptoms in patients with advanced stage lung cancer.
38. Concurrent chemoradiation using weekly versus tri-weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck (SCCHN): A comparative analysis.
39. Trimodality therapy in the treatment of stage IIIA non-small cell lung cancer (NSCLC): Analysis of the National Cancer Database.
40. Comparison of concurrent use of carboplatin-Paclitaxel versus cisplatin-etoposide with thoracic radiation for stage III NSCLC patients: A systematic review.
41. Pemetrexed versus taxane-containing platinum doublet therapy for advanced non-squamous non-small cell lung cancer (NSCLC): A systematic analysis.
42. PD-L1, PD-1, and CTLA-4 as prognostic biomarkers in resected non-small cell lung cancer.
43. Aneuploidy of anaplastic lymphoma kinase (ALK) gene and association with non squamous lung cancer patient characteristics and outcomes.
44. Pulmonary sarcomatoid carcinoma: An analysis of the National Cancer Database.
45. Management approaches and outcomes of lung cancer patients hospitalized for malignant pleural effusions.
46. Access to Children’s Oncology Group phase I clinical trials: Racial/ethnic dissimilarities in participation.
47. Predictors and outcomes of venous thromboembolism (VTE) in hospitalized lung cancer patients: A nationwide inpatient sample (NIS) database analysis.
48. HER2 mutations in lung adenocarcinoma: A report from the Lung Cancer Mutation Consortium (LCMC).
49. Clinical characteristics and outcomes of atypical carcinoid (AC) tumor of the lung: A Surveillance, Epidemiology, and End Results database analysis.
50. Trends in small cell lung cancer (SCLC) survival: Predictors and impact of systemic therapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.